The results of this study showed that, although in the whole GC patients (group A and group B) SPARC expression did not significantly relate to prognosis, subgroup analysis showed that in group A SPARC expression in post-chemotherapy specimens was associated with poor prognosis, which is probably related to the small size. The gene discussed is SPARC; the disease is gastric cancer.